1. Home
  2. TECX vs LXFR Comparison

TECX vs LXFR Comparison

Compare TECX & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.01

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$15.18

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
LXFR
Founded
2019
1898
Country
United States
United States
Employees
51
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
421.4M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
TECX
LXFR
Price
$21.01
$15.18
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$80.40
N/A
AVG Volume (30 Days)
529.5K
113.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
3.32%
EPS Growth
N/A
1071.43
EPS
N/A
0.40
Revenue
N/A
$391,900,000.00
Revenue This Year
N/A
$0.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$39.13
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$9.41
52 Week High
$27.64
$16.03

Technical Indicators

Market Signals
Indicator
TECX
LXFR
Relative Strength Index (RSI) 48.41 49.49
Support Level $20.52 $14.74
Resistance Level $25.39 $16.00
Average True Range (ATR) 2.35 0.45
MACD -0.23 -0.08
Stochastic Oscillator 45.94 12.64

Price Performance

Historical Comparison
TECX
LXFR

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: